What is the recommended treatment for pericarditis occurring in acute rheumatic fever in children and adolescents?

Treatment of Pericarditis in Acute Rheumatic Fever

For pericarditis occurring in acute rheumatic fever in children and adolescents, treat with high-dose aspirin (80-100 mg/kg/day divided every 6-8 hours) or corticosteroids (prednisone 1-2 mg/kg/day) for 12 weeks total, combined with penicillin for streptococcal eradication. 1

Critical Context: Rheumatic Fever Pericarditis is Different

Pericarditis in rheumatic fever requires a fundamentally different approach than idiopathic or viral pericarditis. The 2015 ESC guidelines 2 explicitly state that corticosteroids are NOT recommended as first-line therapy for acute pericarditis (Class III recommendation) and should be avoided due to promoting chronicity and recurrence. However, these guidelines also acknowledge that corticosteroids should be considered when there is a specific indication such as autoimmune disease 2.

Rheumatic fever represents exactly this exception—it is an autoimmune/post-streptococcal inflammatory condition where the underlying pathophysiology differs from typical pericarditis.

Treatment Algorithm for Rheumatic Pericarditis

1. Streptococcal Eradication (Mandatory First Step)

• Benzathine penicillin G: Single intramuscular dose (600,000 units if <27 kg; 1.2 million units if ≥27 kg), OR
• Penicillin V oral: 250-500 mg 2-3 times daily for 10 days, OR
• Azithromycin: If penicillin allergic 1

2. Anti-inflammatory Therapy (Choose Based on Severity)

For mild-to-moderate carditis:

• Aspirin: 80-100 mg/kg/day divided every 6-8 hours
• Continue for 12 weeks total with gradual taper 1
• Monitor salicylate levels (therapeutic range 20-25 mg/dL)

For severe carditis (heart failure, significant effusion, or cardiomegaly):

• Corticosteroids: Prednisone 1-2 mg/kg/day (maximum 60-80 mg/day)
• Continue until clinical improvement and ESR normalization
• Begin aspirin taper as steroids are tapered
• Total anti-inflammatory duration: 12 weeks 1, 3

The evidence from a sequential analysis trial showed corticosteroids produce significantly better clinical response and faster ESR reduction compared to salicylates alone in rheumatic carditis 3. This supports their use despite general pericarditis guidelines recommending against first-line steroid use.

3. Key Differences from Standard Pericarditis Management

DO NOT follow typical pericarditis protocols:

• Do NOT use colchicine as first-line adjunct (no evidence in rheumatic fever; colchicine is for idiopathic/viral pericarditis) 2
• Do NOT avoid corticosteroids in severe rheumatic carditis—they are indicated 1, 3
• Treatment duration is longer: 12 weeks vs. 1-2 weeks for typical pericarditis [1 vs 2]

4. Monitoring Parameters

• C-reactive protein (CRP) and ESR: Guide treatment duration and taper
• ECG and echocardiogram: Assess for effusion, tamponade, valvular involvement
• Clinical symptoms: Chest pain, fever resolution
• Salicylate levels if using aspirin

5. Activity Restriction

• Restrict physical activity beyond ordinary sedentary life until:
  • Symptoms resolve
  • CRP/ESR normalize
  • ECG and echocardiogram normalize
• For athletes: Minimum 3 months restriction from competitive sports 2

6. Secondary Prophylaxis (Critical for Prevention)

After acute treatment, initiate long-term secondary prophylaxis:

• Benzathine penicillin G: 1.2 million units IM every 3-4 weeks
• Duration depends on cardiac involvement:
  • No carditis: Until age 21 or 5 years post-attack
  • Carditis without residual disease: Until age 25 or 10 years post-attack
  • Carditis with residual disease: Until age 40 or lifelong 1, 4

Common Pitfalls to Avoid

1. Applying standard pericarditis guidelines to rheumatic fever: The ESC guidelines are for idiopathic/viral pericarditis, not autoimmune conditions 2

2. Undertreating with short courses: Rheumatic fever requires 12 weeks of anti-inflammatory therapy, not 1-2 weeks 1

3. Missing streptococcal eradication: Always treat the underlying infection first 1, 5

4. Failing to initiate secondary prophylaxis: This prevents recurrent attacks and progressive cardiac damage 1, 4

5. Using colchicine inappropriately: No evidence supports colchicine in rheumatic fever pericarditis; it's for recurrent idiopathic pericarditis 2

When to Consider Hospitalization

Admit patients with:

• Moderate-to-large pericardial effusion
• Signs of tamponade
• Severe carditis with heart failure
• Fever >38°C
• Subacute presentation
• Need for IV antibiotics or close monitoring 2

The key distinction is recognizing that rheumatic fever pericarditis is part of a systemic autoimmune process requiring disease-specific treatment, not the typical viral/idiopathic pericarditis pathway outlined in general cardiology guidelines.